Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson’s disease
- 31 July 2007
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 27 (1), 11-23
- https://doi.org/10.1016/j.nbd.2007.03.013
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Developing a preclinical model of Parkinson's disease: A study of behaviour in rats with graded 6-OHDA lesionsBehavioural Brain Research, 2006
- Molecular and cellular alterations in the Pitx3-deficient midbrain dopaminergic systemMolecular and Cellular Neuroscience, 2005
- Testing forelimb placing “across the midline” reveals distinct, lesion-dependent patterns of recovery in ratsExperimental Neurology, 2005
- D2Dopamine Receptors Colocalize Regulator of G-Protein Signaling 9-2 (RGS9-2) via the RGS9 DEP Domain, and RGS9 Knock-Out Mice Develop Dyskinesias Associated with Dopamine PathwaysJournal of Neuroscience, 2005
- Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-SynucleinJournal of Neuroscience, 2004
- Stimulation of cannabinoid receptors reduces levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate model of Parkinson's diseaseMovement Disorders, 2002
- Striatal fosB Expression Is Causally Linked with l-DOPA-Induced Abnormal Involuntary Movements and the Associated Upregulation of Striatal Prodynorphin mRNA in a Rat Model of Parkinson's DiseaseNeurobiology of Disease, 1999
- D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal NeuronsScience, 1990
- Induction of chorea and dystonia in parkinsonian primatesMovement Disorders, 1990
- Localization of striatal opioid gene expression, and its modulation by the mesostriatal dopamine pathway: An in situ hybridization studyJournal of Molecular Neuroscience, 1989